Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
about
L-asparaginase in the treatment of patients with acute lymphoblastic leukemiaNon-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadAsparaginase pharmacokinetics and implications of therapeutic drug monitoringHow to manage asparaginase hypersensitivity in acute lymphoblastic leukemiaPilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupConservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemiaEffective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.The management of high-risk lymphoblastic leukaemia in children.Topoisomerase II inhibitor-related acute myeloid leukaemia.Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaHematopoietic stem cell transplantation for leukemiaThe clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia.Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment.L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseThe toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.Asparagine synthetase chemotherapy.Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology groupResults of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaLessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia.Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic lClinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphoma.Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia.Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment StrategiesPolyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).Is Erwinase Necessary for all Children With ALL and Allergic Reactions to E. coli Asparaginase?Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapyOutcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinomaErwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia.
P2860
Q26738640-5C7989FC-C36D-4E5B-A9D6-F57BBFFAB41DQ26797513-F4E035E9-31FE-4D2B-8B80-FC20543E9D05Q27026476-2B2F53EA-39DD-4AFA-BAAD-3D829C847082Q27026952-BDFCADA9-3CA1-4122-83A4-E9D1C986B9C9Q30417943-90AE84A7-E997-48CB-AD52-79108D177C4CQ33611308-14E63A9B-3B39-44B7-AEB9-28DFFF82F04DQ33744912-BA2CE5B4-9CE8-4AD3-9F25-903CA588F574Q33848509-093CBA39-E17A-4A9F-840D-EB92AC7184D7Q33940241-B731BA40-B101-43B4-B0E1-8CDA8FF7BCC5Q33943185-59B5B2B5-E18B-427A-B404-DF72D55CA821Q34034180-C56C4D99-AA87-43B1-BCFD-5041F6840035Q34071686-0CD701CB-0C01-45D3-96D3-C55F00CDC014Q34325815-7296BD6B-6147-4320-9B92-79F45EA0B2A3Q34400424-27F211B1-AD46-4E68-8F42-B8959590FBB5Q34463641-002D0B0B-F74D-4EC9-86AF-A4B91AE6DE9AQ34535185-EB100F25-A415-4416-ABD4-19E9F35DAE04Q34992080-93804AA2-27B0-4708-97C1-8A97FA19F61FQ35616085-39D07CFE-F034-42D9-B1F1-560DADA9B5E3Q35667279-3A365D79-D053-4B0E-88D5-EE27CF199C51Q35776973-C39007E0-FEE6-49B3-B918-497CB1B5D7F5Q35797649-69B847A0-AC20-4EDE-BD1A-01433F3EECB8Q35849907-B0EB518C-F38E-4EA8-B077-41BFC4B0BF95Q35958818-131B1FDC-F941-4E1B-9271-C64092022986Q35989408-709794B0-E8BB-4CD4-AA6E-AE605C299D6DQ36105259-27EDA6EE-490E-4E27-8F42-D43B2078F2E3Q36452241-6FCB44BB-3D8D-4B26-B344-DC4E0DD80D6FQ36469789-B95B75C8-3D0A-45A5-8313-319B42F1E9C1Q36570330-680E504C-FC31-4A6E-A2C4-9EA749ED6819Q36586248-F8780EBA-8928-4E58-A4AF-093DB9F1029EQ36762608-A33DEFCF-F2CB-42CE-ADE4-66B7999499ECQ36805855-F1B729DA-00BD-4893-92A6-4ECE8A841E36Q36854190-3DE05A40-5487-4F23-960E-96FB03CC3F85Q36996143-BD86D764-8C07-4A71-8943-356EAF944571Q37003403-5ADC7DF0-34D7-4B79-9729-943020D8B244Q37046992-553AC2AF-6B22-4A02-B1BC-2CFDF096FF70Q37126934-053EED5B-75D0-465F-B34D-BB71993393DCQ37346340-53957DD1-279E-4BFA-A3C8-DCEF2BDF2F82Q37522294-8237D3B1-54CA-4960-868E-DDA588782096Q37670065-418A39F0-2829-44FE-8F03-A89F984BE08CQ38248280-902E9040-A2B9-4FD7-BE1A-226730C6A963
P2860
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@ast
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@en
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@nl
type
label
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@ast
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@en
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@nl
prefLabel
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@ast
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@en
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@nl
P2093
P356
P1433
P1476
Intensive high-dose asparagina ...... ediatric Oncology Group study.
@en
P2093
Kurtzberg J
P2888
P304
P356
10.1038/SJ/LEU/2401310
P577
1999-03-01T00:00:00Z
P6179
1056650300